Carl Zeiss Meditec AG - Asset Resilience Ratio
Carl Zeiss Meditec AG (AFX) has an Asset Resilience Ratio of 0.72% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Carl Zeiss Meditec AG carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2018)
This chart shows how Carl Zeiss Meditec AG's Asset Resilience Ratio has changed over time. See Carl Zeiss Meditec AG shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Carl Zeiss Meditec AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Carl Zeiss Meditec AG.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €24.90 Million | 0.72% |
| Total Liquid Assets | €24.90 Million | 0.72% |
Asset Resilience Insights
- Limited Liquidity: Carl Zeiss Meditec AG maintains only 0.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Carl Zeiss Meditec AG Industry Peers by Asset Resilience Ratio
Compare Carl Zeiss Meditec AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Carl Zeiss Meditec AG (2014–2018)
The table below shows the annual Asset Resilience Ratio data for Carl Zeiss Meditec AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-09-30 | 0.07% | €1.17 Million ≈ $1.36 Million |
€1.66 Billion ≈ $1.94 Billion |
-0.20pp |
| 2017-09-30 | 0.27% | €4.39 Million ≈ $5.13 Million |
€1.62 Billion ≈ $1.90 Billion |
-9.38pp |
| 2015-09-30 | 9.66% | €110.00 Million ≈ $128.60 Million |
€1.14 Billion ≈ $1.33 Billion |
-0.93pp |
| 2014-09-30 | 10.59% | €110.00 Million ≈ $128.60 Million |
€1.04 Billion ≈ $1.21 Billion |
-- |
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more